Expertise in Action: Turning Regulatory Programs into Executable Momentum

In Expertise in Action, ProductLife Group spotlights the people whose expertise helps transform scientific ambition into real-world progress. For Carolina Ahrendt, that means bringing structure, clarity, and executional momentum to regulatory programs at some of the most critical stages of development.

As products move towards a New Drug or Biologics License Application submission and commercialization, success depends not only on the strength of the science, but on the ability to coordinate people, timelines, decisions, and communication under pressure. Regulatory program management is where strategy becomes execution.

Carolina has supported five U.S. marketing applications that went on to receive FDA approval in areas including oncology, rare diseases, and schizophrenia. These engagements were especially meaningful because several involved smaller biotech companies with limited late-stage development experience, approaching a major value inflection point as they moved from development-stage organizations toward becoming commercial companies, and getting one step closer to reaching more patients.

Her role in these contexts is to help bring order where complexity can easily become overwhelming. By managing communications, timelines, stakeholder reporting, and scenario planning, she helps teams stay aligned and move forward even when obstacles emerge. It is a form of leadership that often operates both behind the scenes and at the forefront with cross-functional teams, but has a direct impact on whether strategy can actually be delivered.

As a Principal Consultant in the Regulatory Affairs Group, Carolina specializes in program management and leadership. Her perspective on excellence is highly practical: it is the ability to communicate effectively with a wide range of stakeholders, from scientists to CEOs, using the right mix of strategic planning, risk management, project plans, Gantt charts, milestones, dashboards, and decision structures to keep development moving.

One of the most important lessons she has learned is that there is no single communication model that works for every client. Each team has its own dynamic, level of maturity, and need for clarity. Effective leadership in this kind of environment means adapting without losing direction while concurrently keeping the patients front and center.

This reflects something she particularly values about PLG’s way of working: a collaborative culture that spans countries, service areas, and functions with the mission to improve human health. When challenges exceed the boundaries of one discipline, there is always someone ready to contribute expertise, share perspective, and help move the work forward together.

Carolina’s contribution to life sciences may not happen at the point of care, but it is deeply connected to patient impact. By helping companies turn strategies into executable plans and navigate complex approval pathways, she supports the timely availability of treatments for patients who need new options.

Her work is a reminder that in life sciences, progress often depends on the people who create clarity, maintain alignment, and keep momentum alive when complexity threatens to slow everything down.

Ready to navigate complex approval pathways and bring treatments to patients faster? Contact us: